BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

646 related articles for article (PubMed ID: 19567259)

  • 1. Preparation and characterization of chitosan/polyguluronate nanoparticles for siRNA delivery.
    Lee DW; Yun KS; Ban HS; Choe W; Lee SK; Lee KY
    J Control Release; 2009 Oct; 139(2):146-52. PubMed ID: 19567259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and characterisation of chitosan nanoparticles for siRNA delivery.
    Katas H; Alpar HO
    J Control Release; 2006 Oct; 115(2):216-25. PubMed ID: 16959358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex.
    Cafaggi S; Russo E; Stefani R; Leardi R; Caviglioli G; Parodi B; Bignardi G; De Totero D; Aiello C; Viale M
    J Control Release; 2007 Aug; 121(1-2):110-23. PubMed ID: 17601625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of alginate inclusion on the vector properties of chitosan-based nanoparticles.
    Douglas KL; Piccirillo CA; Tabrizian M
    J Control Release; 2006 Oct; 115(3):354-61. PubMed ID: 17045691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
    Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
    Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrafine chitosan nanoparticles as an efficient nucleic acid delivery system targeting neuronal cells.
    Malhotra M; Kulamarva A; Sebak S; Paul A; Bhathena J; Mirzaei M; Prakash S
    Drug Dev Ind Pharm; 2009 Jun; 35(6):719-26. PubMed ID: 19514987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional gene silencing mediated by chitosan/siRNA nanocomplexes.
    Ji AM; Su D; Che O; Li WS; Sun L; Zhang ZY; Yang B; Xu F
    Nanotechnology; 2009 Oct; 20(40):405103. PubMed ID: 19752491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of aligned hematite nanoparticles on chitosan-alginate films.
    Sreeram KJ; Nidhin M; Nair BU
    Colloids Surf B Biointerfaces; 2009 Jul; 71(2):260-7. PubMed ID: 19303261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein release kinetics for core-shell hybrid nanoparticles based on the layer-by-layer assembly of alginate and chitosan on liposomes.
    Haidar ZS; Hamdy RC; Tabrizian M
    Biomaterials; 2008 Mar; 29(9):1207-15. PubMed ID: 18076987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chitosan-alginate nanoparticles and ultrasound on the efficiency of gene transfection of human cancer cells.
    Yang SJ; Chang SM; Tsai KC; Chen WS; Lin FH; Shieh MJ
    J Gene Med; 2010 Feb; 12(2):168-79. PubMed ID: 19943342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of preparative variables on small interfering RNA loaded Poly(D,L-lactide-co-glycolide)-chitosan submicron particles prepared by emulsification diffusion method.
    Katas H; Chen S; Osamuyimen AA; Cevher E; Oya Alpar H
    J Microencapsul; 2008 Dec; 25(8):541-8. PubMed ID: 18465303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alginate and chitosan particles as drug delivery system for cell therapy.
    Ciofani G; Raffa V; Menciassi A; Dario P
    Biomed Microdevices; 2008 Apr; 10(2):131-40. PubMed ID: 17874301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.
    Park S; Jeong EJ; Lee J; Rhim T; Lee SK; Lee KY
    Carbohydr Polym; 2013 Jan; 92(1):57-62. PubMed ID: 23218265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms.
    Yang SJ; Lin FH; Tsai HM; Lin CF; Chin HC; Wong JM; Shieh MJ
    Biomaterials; 2011 Mar; 32(8):2174-82. PubMed ID: 21163518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen.
    Borges O; Silva M; de Sousa A; Borchard G; Junginger HE; Cordeiro-da-Silva A
    Int Immunopharmacol; 2008 Dec; 8(13-14):1773-80. PubMed ID: 18801462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and characterization of alginate coated low molecular weight chitosan nanoparticles as new carriers for oral vaccine delivery in mice.
    Biswas S; Chattopadhyay M; Sen KK; Saha MK
    Carbohydr Polym; 2015 May; 121():403-10. PubMed ID: 25659715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chitosan-alginate hybrid scaffolds for bone tissue engineering.
    Li Z; Ramay HR; Hauch KD; Xiao D; Zhang M
    Biomaterials; 2005 Jun; 26(18):3919-28. PubMed ID: 15626439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
    Chen F; Zhang ZR; Huang Y
    Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan coated sodium alginate-chitosan nanoparticles loaded with 5-FU for ocular delivery: in vitro characterization and in vivo study in rabbit eye.
    Nagarwal RC; Kumar R; Pandit JK
    Eur J Pharm Sci; 2012 Nov; 47(4):678-85. PubMed ID: 22922098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cationic nanoparticles of biodegradable copolymers as siRNA delivery system for hepatitis B treatment.
    Wang J; Feng SS; Wang S; Chen ZY
    Int J Pharm; 2010 Nov; 400(1-2):194-200. PubMed ID: 20801205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.